Drug Abuse Warning Network (DAWN)
Principal Investigator(s): View help for Principal Investigator(s) SAMHSA
Version: View help for Version V2
Name | File Type | Size | Last Modified |
---|---|---|---|
|
application/zip | 12.7 MB | 02/09/2025 08:52:AM |
|
application/zip | 13.3 MB | 02/09/2025 07:31:AM |
|
application/pdf | 5.5 MB | 02/09/2025 07:31:AM |
|
application/pdf | 900 KB | 02/09/2025 07:32:AM |
|
application/zip | 15.6 MB | 02/09/2025 07:32:AM |
|
application/zip | 16.6 MB | 02/09/2025 07:31:AM |
|
application/pdf | 5.5 MB | 02/09/2025 07:31:AM |
|
application/pdf | 903.3 KB | 02/09/2025 07:32:AM |
|
application/zip | 15.6 MB | 02/09/2025 07:32:AM |
|
application/zip | 16.6 MB | 02/09/2025 07:30:AM |
- Total of 42 records. Records per page
- « previous Page of 5
- next »
Project Citation:
SAMHSA. Drug Abuse Warning Network (DAWN). Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2025-04-01. https://doi.org/10.3886/E218682V2
Project Description
Project Title:
View help for Project Title
Drug Abuse Warning Network (DAWN)
Summary:
View help for Summary
Legacy DAWN has data from 1997 through 2011 shared in public-use files (PUFs). These are full datasets treated with confidentiality protections. The PUF codebooks give more information on specific data treatments. Note, the codebooks may not contain all variables. This data used a longitudinal probability sample of hospitals in the United States. The PUFs contain information on emergency department (ED) visits related to substance use and misuse. This data can be used to track trends and understand the impact of substance use on healthcare.In 2018, DAWN was reestablished to use hospital-based and probability sample-based surveillance.
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.